| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/26/2007 | US20070093451 Compositions of estrogen-cyclodextrin complexes |
| 04/26/2007 | US20070093450 Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction |
| 04/26/2007 | US20070093449 Novel IV formulation of tipifarnib |
| 04/26/2007 | US20070093448 Complexes that consist of vitamin D compounds or analogs thereof with a 5Z,7E,10(19)-triene system and methylated derivatives of beta-cyclodextrin |
| 04/26/2007 | US20070093447 Method for crosslinking beta-cyclodextrin for cholesterol trapping and regeneration thereof |
| 04/26/2007 | US20070093446 Orally bioavailable compounds and methods for inhibiting platelet aggregation |
| 04/26/2007 | US20070093445 RNA interference mediating small RNA molecules |
| 04/26/2007 | US20070093441 useful to efficiently induce self-specific immune responses; comprising a virus-like particle and at least one protein, or peptide of IL-5, IL-13 and/or eotaxin |
| 04/26/2007 | US20070093434 Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 04/26/2007 | US20070093433 Aminoglycoside antibiotics for use as vap-1/ssao inhibitors |
| 04/26/2007 | US20070093432 Camptothecin derivatives as chemoradiosensitizing agents |
| 04/26/2007 | US20070093431 N-(3-amino-2,2-dimethyl-3-oxopropyl)-2,7-di(1-methylethyl)-4-hydroxy-5-amino-8-[4-methoxy-3-(3-methoxy-propoxy)phenyl]-octanamide as renin inhibitor and an antidiabetic agent (insulin secretion enhancer or sensitizer); synergistic effect on related isolated systolic hypertension and vascular compliance |
| 04/26/2007 | US20070093430 Interferons; polyoxyethylene glycol |
| 04/26/2007 | US20070093429 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents |
| 04/26/2007 | US20070093419 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 04/26/2007 | US20070093418 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/26/2007 | US20070093416 Human beta-defensin secretion promoter |
| 04/26/2007 | US20070093413 Histone deacetylases, and uses related thereto |
| 04/26/2007 | US20070093411 Diabetic inhalant formulation including surfactant and optionally preservative, isotonicizing agent, buffer and/or excipient |
| 04/26/2007 | US20070092944 glycosylation endproducts of polyketides, glycoproteins or polyketide-peptide substrates with microbial glycosyltransferases |
| 04/26/2007 | US20070092918 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer |
| 04/26/2007 | US20070092902 Methods for Detection of Promoter Polymorphism in UGT Gene Promoter |
| 04/26/2007 | US20070092631 Composition and foods for lowering glycemic index |
| 04/26/2007 | US20070092586 Compositions and methods for the administration psychotropic drugs which modulate body weight |
| 04/26/2007 | US20070092585 Cancer chemotherapy compositions comprising PI3K pathways modulators and triptolide |
| 04/26/2007 | US20070092584 comprising a thiazolidinedione, one or more of chromium picolinate or chromium polynicotinate; bioavailable source of vanadium is vanadyl sulfate; synergistic mixture |
| 04/26/2007 | US20070092583 Cold remedy composition comprising zinc salts |
| 04/26/2007 | US20070092582 Methods of preserving ophthalmic solutions and preserved ophthalmic solutions |
| 04/26/2007 | US20070092579 Medical Products and Parenteral Formulations |
| 04/26/2007 | US20070092578 Skin rejuvinating supplement |
| 04/26/2007 | US20070092576 Compositions containing opioid antagonists |
| 04/26/2007 | US20070092574 Controlled released compositions |
| 04/26/2007 | US20070092573 Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist |
| 04/26/2007 | US20070092572 Bone cement compositions and the like comprising an RNAIII-inhibiting peptide |
| 04/26/2007 | US20070092568 Galantamine compositions |
| 04/26/2007 | US20070092567 Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin |
| 04/26/2007 | US20070092566 Oral sustained-release tablet |
| 04/26/2007 | US20070092564 comprising a drug and a matrix, wherein the matrix contains an amino acid and pullulan and the ratio by weight of the amino acid to pullulan is 0.1 to 10, wherein the amino acid is selected from glycine, serine, arginine and a combination thereof; disintegrates rapidly in mouth |
| 04/26/2007 | US20070092563 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 04/26/2007 | US20070092562 Product and process for increasing compactibility of carbohydrates |
| 04/26/2007 | US20070092561 Water-Soluble Aspirin Composition |
| 04/26/2007 | US20070092558 Methods of Preparing Targeted Immunoliposomes |
| 04/26/2007 | US20070092554 Sexual Dysfunction Compounds |
| 04/26/2007 | US20070092553 Compositions and methods of making rapidly dissolving lonically masked formulations |
| 04/26/2007 | US20070092552 Chewable lozenge cold remedy composition and method for making same |
| 04/26/2007 | US20070092551 Therapeutic agent |
| 04/26/2007 | US20070092549 Delivering magnetic antimitotic agent in manner more toxic to cancer than normal cells while maintaining high concentration for a sustained period of time |
| 04/26/2007 | US20070092540 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof |
| 04/26/2007 | US20070092539 Method of preparing an aqueous meloxicam solution and aqueous solution thus produced |
| 04/26/2007 | US20070092529 Using gene encoding transmembrane ptorein |
| 04/26/2007 | US20070092526 Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use |
| 04/26/2007 | US20070092523 Combination Therapy Of Respiratory Diseases Using Antibodies |
| 04/26/2007 | US20070092512 Preventing bacterial or viral infectivity and composition containing infection preventing additive |
| 04/26/2007 | US20070092510 Gene expression inhibition; drug screening; reduction of nociception; modulation of the activity and/or expression of a chloride transporter, such as the KCC2 potassium-chloride cotransporter |
| 04/26/2007 | US20070092506 Use of rapamycin and agents that inhibit B7 activity in immunomodulation |
| 04/26/2007 | US20070092502 Method of Treating Glaucoma |
| 04/26/2007 | US20070092500 Methods and pharmaceutical compositions for differentially altering gene expression to provide neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma and metal poisoning |
| 04/26/2007 | US20070092499 Method for changing genetic properties of eukaryotic organism |
| 04/26/2007 | US20070092483 Surgical adhesive compostion and process for enhanced tissue closure and healing |
| 04/26/2007 | US20070092481 Thickened cyanoacrylate compositions |
| 04/26/2007 | US20070092476 Compounds and use to reduce the formation of malodour |
| 04/26/2007 | US20070092474 Carnitine salt, preliposome which contains it and dermocosmetic formula for topical use based upon said carnitine salt |
| 04/26/2007 | US20070092472 solution for topical application to the skin consists of solutes and a solvent, where the solutes include ascorbate, tropocollagen factors, copper, and zinc gluconate; tropocollagen factors include L-proline, glycine and L-lysine; formulated to provide accelerated production of collagen proteins |
| 04/26/2007 | US20070092469 Topically applied Glucosamine Sulfate and all its related, precursor, and derivative compounds significantly increases the skin's natural produciton of hyaluronic acid for the rejuvenation of healthier younger-looking skin; while PhosphatidylCholine is required to replace its deficiency caused by topical Dimethylaminoethanol (DMAE) |
| 04/26/2007 | US20070092467 Oxyacetamide compounds useful for stimulating or inducing the growth and/or retarding the loss of keratin fibers |
| 04/26/2007 | US20070092466 in combination with carrier, and optionally activity enhancer; arresting or reversing hair loss, or both, and promoting hair growth; also a mascara; thickening and darkening hair |
| 04/26/2007 | US20070092465 Methods for enhancing the morphology, tone, texture and/or appearance of skin or hair using a Meadowlactone |
| 04/26/2007 | US20070092456 Protectant of periodontal membranes |
| 04/26/2007 | US20070092453 Novel Crystalline Forms of Tiotropium Bromide |
| 04/26/2007 | US20070092450 Tissue-specific exogenous optical agents |
| 04/26/2007 | DE10354862B4 Ramipril enthaltende feste pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung Ramipril containing solid pharmaceutical compositions and methods for their preparation |
| 04/26/2007 | DE102005051862A1 Emulsion for treating e.g. skin aging comprises a lipid phase of polar and/or moderately polar, having specified interfacial tension toward water; and at least one 1,2-alkanediol having specified 1-octanol/water distribution coefficient |
| 04/26/2007 | DE102005050953A1 New piperidine compounds are calcitonin gene-related peptide antagonists used for prophylaxis or treatment of e.g. headache, non-insulin dependent diabetes mellitus and cardiovascular disease |
| 04/26/2007 | DE102005050892A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 04/26/2007 | DE102005050729A1 Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption Procedures for preventive-needed hormonal contraception |
| 04/26/2007 | DE102005050497A1 Difluorphenol-Derivate und ihre Verwendung Difluorophenol derivatives and their use |
| 04/26/2007 | DE102005050408A1 Neue Vanilloidrezeptor-Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments |
| 04/26/2007 | DE102005050377A1 Heterocyclische Verbindungen und ihre Verwendung Heterocyclic compounds and their use |
| 04/26/2007 | DE102005050375A1 Tetrazol-Derivate und ihre Verwendung Tetrazole derivatives and their use |
| 04/26/2007 | DE102005049953A1 Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen Carbamoylbenzotriazol derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | DE102005049293A1 Kombinationspräparate von Salzen oder o-Acetylsalicylsäure Combination preparations of salts or O-acetylsalicylic acid |
| 04/26/2007 | CA2628786A1 Compositions containing opioid antagonists |
| 04/26/2007 | CA2628577A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 04/26/2007 | CA2626789A1 Pyrimidinones as casein kinase ii (ck2) modulators |
| 04/26/2007 | CA2626742A1 Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators |
| 04/26/2007 | CA2626704A1 Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof |
| 04/26/2007 | CA2626698A1 Method of treating clostridium difficile-associated diarrhea |
| 04/26/2007 | CA2626681A1 Atr inhibitor |
| 04/26/2007 | CA2626636A1 Method for stimulating intestinal barrier integrity after non-natural birth |
| 04/26/2007 | CA2626635A1 Novel unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof |
| 04/26/2007 | CA2626628A1 Compositions of phosphodiesterase type iv inhibitors |
| 04/26/2007 | CA2626623A1 Method of inhibiting flt3 kinase |
| 04/26/2007 | CA2626615A1 Preventing diseases in infants delivered via caesarean section |
| 04/26/2007 | CA2626613A1 Ramipril formulation with increased stability |
| 04/26/2007 | CA2626612A1 Pharmaceutical compositions of muscarinic receptor antagonists |
| 04/26/2007 | CA2626591A1 Amidine derivatives and their uses as medicine |
| 04/26/2007 | CA2626581A1 Treatment of stress urinary incontinence and mixed urinary incontinence |
| 04/26/2007 | CA2626573A1 Treatment of the symptoms of bladder irritation |
| 04/26/2007 | CA2626568A1 Renin inhibitors nitroderivatives |
| 04/26/2007 | CA2626567A1 Method of preventive on-demand hormonal contraception |